Loading
Biomind Labs Inc. Stock: price and insider trades · Canada
CA·Mcap CA$27.5M
Biomind Labs Inc.: what insiders have been doing
This page follows insider dealings at Biomind Labs Inc. as filed with SEDI. Between 18 October 2025 and 18 October 2026, 1 insider published 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
No insider has bought Biomind Labs Inc. shares on the open market in the past twelve months.
Compared with its exchange (2,105 companies, median 12 filings), a count of 2 filings is below the norm.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$0.36
Analyst consensus
Income statement
EBITDA-CA$779.5k
Net income-CA$850.4k0.0% margin
Valuation
Beta7.22
Balance sheet & cash
Market capCA$27.5M
Total debtCA$728.5k
Free Cash Flow-CA$67.5k
Profitability & ownership
ROA-8087.2%
% insiders36.3%
% institutions0.0%
Last declaration on 5 August 2026
Declarations2 total
100,000 shares@ CA$0.35100.0% of flowOptionsTSXSEDI:4759472
OptionsTSXSEDI:4759469
2 of 2 declarations
About Biomind Labs Inc.
Biomind Labs Inc. is a company listed on the Toronto Stock Exchange that focuses on developing innovative solutions in the life sciences sector. It specializes in the research and commercialization of products related to mental health and well-being.
